Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

PFRDA may take up SBI employees pension corpus
Country"s largest lender State Bank of India"s (SBI) pension corpus could be regulated by the Pension Fund Regulatory and Development Authority (PFRDA), opening a new area for the interim regulator.

Naxalites attack at Balimela disrupts power supply
The power supply in the state was disrupted when around 20 armed Naxalites attacked Balimela hydro power station in south Orissa on Saturday night damaging its Valve House and thus affecting generation at the station.

News of the day

PM to kick off US visit by addressing biz leaders
Prime Minister Manmohan Singh would kick-off his five-day visit to the United States with an address to the influential American business community, which had a key role in the passage of the historic Indo-US civilian nuclear deal. The American business community has termed the Prime Minister"s decision to start the trip by addressing the top leadership of the US business as a "momentous occasion".
Business Opportunities

US FDA say GSK vaccine blocks cancer virus

The US Food and Drug Administration says a vaccine from GlaxoSmithKline successfully blocks the virus that causes most cases of cervical cancer. - Rest In Peace - JB Chemicals gets USFDA nod for its anti-allergic tablets - Unichem Labs gets USFDA nod for hypertension tablets - GSK to launch "promecta" in India by 2009-end - Ranbaxy receives final USFDA approval for Glycopyrolate - Biomarker to help detect CAD at early stage In documents posted online, the FDA says Cervarix, Glaxo"s vaccine against human papilloma virus or HPV, blocked the virus almost 93% of the time. Side effects with the vaccine were mild, such as soreness at the injection site. Cervarix already is approved in nearly 100 other countries, but has been delayed in the United States since 2007 because the FDA said it needed additional data. The agency will ask a panel of vaccine experts next week whether Cervarix should be approved for girls and women ages 10 to 25.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009